Back
Evolent Health Vs. The Chemours Industry Stock Comparison
Buy
56
EVH
Evolent Health
Last Price:
27.41
Seasonality Move:
15.92%
Buy
53
CC
The Chemours
Last Price:
26.13
Seasonality Move:
7.64%
Buy
56
Evolent Health (EVH)
is a Buy
Is Evolent Health a Buy, Sell or Hold?
- The current Evolent Health [EVH] share price is $27.27. The Score for EVH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- EVH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
The Chemours (CC)
is a Buy
Is The Chemours a Buy, Sell or Hold?
- The current The Chemours [CC] share price is $26.00. The Score for CC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- CC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVH Stock Price Chart
What is Evolent Health's stock price today?
-
The Evolent Health share price today is $27.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVH is experiencing selling pressure, which indicates risk of future bearish movement.
CC Stock Price Chart
What is The Chemours's stock price today?
-
The The Chemours share price today is $26.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CC is experiencing selling pressure, which indicates risk of future bearish movement.
EVH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.05 | Sell |
Relative Strength Index (14 RSI): | 26.52 | Sell |
Chaikin Money Flow: | -896842 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.54 - 31.32) | Sell |
Bollinger Bands (100): | (29.42 - 33) | Sell |
CC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 44.1 | Sell |
Chaikin Money Flow: | -1657335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.25 - 27.93) | Sell |
Bollinger Bands (100): | (25.91 - 31.09) | Sell |
EVH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.51 | Sell |
20-day SMA: | 29.51 | Sell |
50-day SMA: | 31.54 | Sell |
200-day SMA: | 29.34 | Sell |
8-day EMA: | 28.28 | Sell |
20-day EMA: | 29.39 | Sell |
50-day EMA: | 30.5 | Sell |
200-day EMA: | 30.27 | Sell |
CC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.88 | Sell |
20-day SMA: | 26.85 | Sell |
50-day SMA: | 26.65 | Sell |
200-day SMA: | 29.29 | Sell |
8-day EMA: | 26.77 | Sell |
20-day EMA: | 26.87 | Sell |
50-day EMA: | 27.2 | Sell |
200-day EMA: | 28.83 | Sell |
Evolent Health Earnings Growth & EVH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.06 per share, an increase this year of $0.50 per share, and an increase next year of $0.42 per share.
The Chemours Earnings Growth & CC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.69 per share, a decrease this year of $1.42 per share, and an increase next year of $2.91 per share.
Evolent Health Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
The Chemours Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |